SILK(Delisted)
Silk Road Medical·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 1
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SILK
Silk Road Medical, Inc.
A medical device company that focused on reducing the risk of stroke and its devastating impact
1213 Innsbruck Dr. Sunnyvale, CA 94089
--
Silk Road Medical, Inc., was incorporated in Delaware on March 21, 2007. They are a medical device company focused on reducing the risk of stroke and its disruptive effects. They believe that the key to stroke prevention is minimally invasive and technologically advanced interventions to safely and effectively treat carotid artery disease, which is one of the leading causes of stroke. They pioneered a new treatment for carotid artery disease called metastatic carotid artery revascularization (TCAR), which they sought as the standard treatment.
Company Financials
EPS
SILK has released its 2024 Q2 earnings. EPS was reported at -0.42, versus the expected -0.38, missing expectations. The chart below visualizes how SILK has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SILK has released its 2024 Q2 earnings report, with revenue of 51.24M, reflecting a YoY change of 13.12%, and net profit of -16.60M, showing a YoY change of -23.13%. The Sankey diagram below clearly presents SILK's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
